Immunogenicity in mice of pneumococcal glycoconjugate vaccines using pneumococcal protein carriers

Vaccine

Volumn 19, Issue 23-24, 2001, Pages 3216-3225

  Lee, Chi Jen ^a   Wang, Theresa R ^a   Frasch, Carl E ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Glycoconjugate; Pneumococcal protein; Polysaccharide

Indexed keywords

AUTOLYSIN; CARRIER PROTEIN; GLYCOCONJUGATE; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; PNEUMOLYSIN; TETANUS TOXOID;

ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BACTERIAL VIRULENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG COATING; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; SEROTYPE; STREPTOCOCCUS INFECTION;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; DRUG CARRIERS; IMMUNOGLOBULIN M; MICE; MICE, INBRED BALB C; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 0035972046     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00033-0     Document Type: Article

References (44)

1. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM 197 in United States infants
2. Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37 000 infants and children: Results of the Northern California Kaiser Permanente trial
3. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants
4. Immunogenicity of Streptococcus pneumoniae type 6B and 14 polysaccharide-tetanus toxoid conjugates and the effect of uncoupled polysaccharide on the antigen-specific immune response
5. Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine
6. A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children
7. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid
8. Carriage issues in relation to vaccination in children
9. Development of a pneumococcal common protein vaccine based a combination of pneumolysin, PspA and PsaA
10. Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against Streptococcus pneumoniae
11. Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice
12. Characterization of hemin binding activity of Streptococcus pneumoniae
13. Production, binding characteristics and protective immunityof monoclonal antibody to pneumococcal type 9V conjugate
14. Protective immunity to cell-surface antigens derived from Streptococcus pneumoniae and new conjugated vaccine development
15. Virulence, immunity, and vaccine related to Streptococcus pneumoniae
16. The direct coupling of oligosaccharides to proteins and derivatized gels
17. Proteins containing reductively aminated disaccharides: Synthesis and chemical characterization
18. Characterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 18C conjugate vaccines
19. Quantitative determination of pneumococcal and meningococcal capsular polysaccharides by light scattering rate nephelometry
20. Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide
21. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
22. Evaluation of previously assigned antibody concentrations in pneumococcal polysaccharide reference serum 89SF by the method of cross-standardization
23. Maternal immunity and antibody response of neonatal mice to pneumococcal type 19F polysaccharide
24. Human isotype-specific enzyme immunoassay for antibodies to pneumococcal polysaccharides
25. Two enzyme linked immunosorbent assays for detecting antibodies against meningococcal capsular polysaccharides A and C
26. Measurement of antibody responses to pneumolysin - A promising method for the etiological diagnosis of pneumococcal pneumonia
27. Standardization of antibody assays for measuring the response to pneumococcal infection and immunization
28. Immune responses of young mice to pneumococcal type 9V polysaccharide-tetanus toxoid conjugate
29. Serological response to Bordetella pertussis
30. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines
31. Antigenic specificity of opsonophagocytic antibodies in rabbit antisera to group B streptococci
32. The autolytic enzyme activity upon pneumococcal cell wall
33. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid
34. Carriage of pneumococci after pneumococcal vaccination
35. Effect of carrier priming on immunogencity of saccharide-protein conjugate vaccines
36. Carrier -induced epitopic suppression, a major issue for synthetic vaccines
37. Immunochemical characterization of cross-reactivity of 9N, 9A, 9L and 9V
38. Cross-immunogenicity of pneumococcal group 9 capsular polysaccharides in adult volunteers
39. Protection of infant mice from challenge with Streptococcus pneumoniae type 19F by immunization with a type 19F polysaccharide-pneumolysoid conjugate
40. Contribution of autolysin to virulece of Streptococcus pneumoniae
41. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines
42. Laboratory correlates of protection against Haemophilus influenzae type b disease. Importance of assessment of antibody avidity and immunologic memory
43. Antipolysaccharide immunoglobulin isotype levels and opsonic activity of antisera: Relationships with protection against Streptococcus pneumoniae infection infection in mice
44. Mechanisms of host defense infection with Streptococcus pneumoniae